169 related articles for article (PubMed ID: 1969454)
1. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
Ellenhorn JD; Schreiber H; Bluestone JA
J Immunol; 1990 Apr; 144(7):2840-6. PubMed ID: 1969454
[TBL] [Abstract][Full Text] [Related]
2. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
3. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
4. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
5. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
[TBL] [Abstract][Full Text] [Related]
6. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
Yoshizawa H; Chang AE; Shu S
J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072
[TBL] [Abstract][Full Text] [Related]
7. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function. Activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down-regulation of cell surface CD4.
Jamali I; Field EH; Fleming A; Cowdery JS
J Immunol; 1992 Mar; 148(6):1613-9. PubMed ID: 1347302
[TBL] [Abstract][Full Text] [Related]
9. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
10. Production of interleukin 2 and interleukin 4 by immune CD4-CD8+ and their role in the generation of antigen-specific cytotoxic T cells.
Horvat B; Loukides JA; Anandan L; Brewer E; Flood PM
Eur J Immunol; 1991 Aug; 21(8):1863-71. PubMed ID: 1907920
[TBL] [Abstract][Full Text] [Related]
11. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
Green-Johnson JM; Szewczuk MR
Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
[TBL] [Abstract][Full Text] [Related]
12. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
Budd RC; Winslow G; Inokuchi S; Imboden JB
J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
[TBL] [Abstract][Full Text] [Related]
13. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
[TBL] [Abstract][Full Text] [Related]
14. Subpopulations of CD8+ cytotoxic T cell precursors collaborate in the absence of conventional CD4+ helper T cells.
Kung JT; Castillo M; Heard P; Kerbacher K; Thomas CA
J Immunol; 1991 Mar; 146(6):1783-90. PubMed ID: 1672332
[TBL] [Abstract][Full Text] [Related]
15. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
Kelso A
J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
[TBL] [Abstract][Full Text] [Related]
16. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.
de Jong R; Brouwer M; Miedema F; van Lier RA
J Immunol; 1991 Apr; 146(7):2088-94. PubMed ID: 1826015
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones.
Chang JC; Zhang L; Edgerton TL; Kaplan AM
J Immunol; 1990 Jul; 145(2):409-16. PubMed ID: 1973181
[TBL] [Abstract][Full Text] [Related]
18. Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.
Kikly K; Dennert G
J Immunol; 1992 Jul; 149(2):403-12. PubMed ID: 1385604
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody.
Tadakuma T; Kizaki H; Odaka C; Kubota R; Ishimura Y; Yagita H; Okumura K
Eur J Immunol; 1990 Apr; 20(4):779-84. PubMed ID: 1971792
[TBL] [Abstract][Full Text] [Related]
20. Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.
De Jong R; Brouwer M; Rebel VI; Van Seventer GA; Miedema F; Van Lier RA
Immunology; 1990 Jul; 70(3):357-64. PubMed ID: 2143171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
